ViAqua Therapeutics Secures $8.25M Funding to Tackle Disease in Aquaculture
Key Takeaways Significant Funding: ViAqua Therapeutics has secured $8.25 million to develop its RNA-based oral delivery platform to improve aquaculture disease resistance. Targeting Major Disease: The company’s first product aims […]